Career Enhancement Program
职业提升计划
基本信息
- 批准号:10472608
- 负责人:
- 金额:$ 15.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-30 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AmericanClinicClinicalClinical ResearchClinical TrialsColoradoDiagnosisDiagnosticDoctor of PhilosophyEducational process of instructingFacultyFellowshipFellowship ProgramFloridaFoundationsFundingGenerationsGrantGrant Review ProcessHeadIndividualIndustryInstitutionInternetLearningMedical StudentsMedicineMentorsMentorshipMitochondriaMitochondrial DiseasesOrganPhysiciansRare DiseasesResearch PersonnelResearch SupportResearch TrainingScientistSeriesSiteSocietiesStudentsTelemedicineTrainingTranslational ResearchUnited States National Institutes of HealthUniversitiesVideoconferencingWorkcareerclinical developmentclinical trial readinesscourse developmentdoctoral studentexperienceinterestlecturesmedical schoolsmeetingsmemberpatient orientedprofessorprogramssymposiumtraining opportunitytranslational medicinevolunteer
项目摘要
The NAMDC Career Enhancement Program consists of the following components:
1. The NAMDC Fellowship Program which offers a unique training opportunity to senior postdoctoral
clinical fellows who we anticipate will move on to the attending/assistant professor level in an academic
setting as well-trained clinician scientists. The focus is on translational medicine, teaching of diagnostic
expertise and the development of clinical trials expertise. We aim to train the first of a new generation of
clinician scientists who will be well equipped to move the promising new treatments for mitochondrial
disease into the clinical arena. Ten training sites are collaborating in this program. These sites; Columbia,
San Diego, Seattle, Cleveland, Hamilton, CHOP, Baylor, University of Colorado, Mayo Clinic and the
University of Florida are all leading institutions in the field of mitochondrial medicine. World renowned
faculty are to be found at each site. Our current fellow will and 2 prior fellows have participated in RDCRN
training course where they present a summary of their work.
2. The fellowship program is held together by telemedicine conferences involving all consortium sites with
monthly Zoom video conferencing. These conferences are well attended by faculty, students and NIH
representatives. Participation is offered to RDCRN trainees.
3. Career enhancements include (A) The addition of a didactic core lecture series on Clinical Trial readiness
which will be available as an online lecture series. Dr. Peter Stacpoole at the University of Florida has
volunteered to head this course development. He has many years of NIH and industry sponsored clinical
trials experience. (B) The directors of the 10 Career Enhancement Sites have agreed to post a
comprehensive series of lectures on management of mitochondrial disease. (C) The Mitochondrial Medicine
Society (MMS) is currently developing a series of organ-specific mitochondrial disease lectures to be CME-
certified by the UMDF and made available on-line.
4. Funds to be provided by the UMDF will be used to attract young physicians, medical students, MD/PhD
students and recent graduates heading to medical school to the field of mitochondrial medicine. We plan to
provide $20K individual grants annually to candidates in 2 of our NAMDC Career Enhancement Sites.
Proposals will be reviewed by a committee of Site Directors along with the UMDF grant review process. In
addition, an annual retreat will take place on the day following the UMDF annual meeting where the
awardees and the NAMDC fellow can interact with and present their work to the site directors.
NAMDC职业提升计划由以下部分组成:
1.NAMDC奖学金计划为高级博士后提供独特的培训机会
我们预计的临床研究员将晋升为主治医师/助理教授级别的学术
设置为训练有素的临床医生科学家。重点是转化医学,诊断学的教学
专业知识和临床试验专业知识的发展。我们的目标是培养新一代的第一批
临床科学家将做好充分准备,推动有前途的线粒体新疗法的发展
将疾病带入临床舞台。十个培训站点将在这个项目中进行合作。这些网站;哥伦比亚,
圣地亚哥、西雅图、克利夫兰、汉密尔顿、CHOP、贝勒、科罗拉多大学、梅奥诊所和
佛罗里达大学都是线粒体医学领域的领先机构。享誉世界
每个地点都有教员。我们目前的研究员Will和两名之前的研究员已经参加了RDCRN
培训课程,他们在此介绍他们的工作总结。
2.研究金方案是通过远程医疗会议一起举行的,所有财团地点都有
每月一次的Zoom视频会议。参加这些会议的有教职员工、学生和美国国立卫生研究院。
各位代表。RDCRN实习生可参加。
3.职业发展方面的改进包括:(A)增加了关于临床试验准备情况的核心讲授系列
它将以在线系列讲座的形式提供。佛罗里达大学的彼得·斯塔克普尔博士
自愿领导这门课程的开发。他有多年的美国国立卫生研究院和工业赞助的临床
审判经验。(B)10个职业提升网站的董事已同意张贴
线粒体疾病管理综合系列讲座。(C)线粒体医学
MMS(MMS)目前正在开发一系列针对器官特定线粒体疾病的讲座,将被称为CME-
通过UMDF认证,并在网上提供。
4.UMDF提供的资金将用于吸引年轻医生、医学生、医学博士
前往医学院学习线粒体医学领域的学生和应届毕业生。我们计划
每年向我们两个NAMDC职业提升网站的候选人提供20000美元的个人助学金。
提案将与UMDF赠款审查程序一起由SITE主管委员会审查。在……里面
此外,年度务虚会将在UMDF年会的第二天举行,届时
获奖者和NAMDC研究员可以与站点主任互动并向站点主任展示他们的工作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD H HAAS其他文献
RICHARD H HAAS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD H HAAS', 18)}}的其他基金
Phase 2 Study of Levetiracetam for Neonatal Seizures
左乙拉西坦治疗新生儿癫痫的 2 期研究
- 批准号:
8545585 - 财政年份:2012
- 资助金额:
$ 15.76万 - 项目类别:
Phase 2 Study of Levetiracetam for Neonatal Seizures
左乙拉西坦治疗新生儿癫痫的 2 期研究
- 批准号:
8730477 - 财政年份:2012
- 资助金额:
$ 15.76万 - 项目类别:
Phase 2 Study of Levetiracetam for Neonatal Seizures
左乙拉西坦治疗新生儿癫痫的 2 期研究
- 批准号:
8417621 - 财政年份:2012
- 资助金额:
$ 15.76万 - 项目类别:
MITOCHONDRIAL MECHANISM IN HUMAN LACTIC ACIDOSIS LABORATORY STUDIES
人体乳酸酸中毒实验室研究中的线粒体机制
- 批准号:
8166789 - 财政年份:2009
- 资助金额:
$ 15.76万 - 项目类别:
相似海外基金
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 15.76万 - 项目类别:
Clinical and Economic Impact of Teleneurology vs Standard in Clinic Care for Multiple Sclerosis: A Randomized Trial
远程神经学与多发性硬化症临床护理标准的临床和经济影响:随机试验
- 批准号:
10710059 - 财政年份:2022
- 资助金额:
$ 15.76万 - 项目类别:
Clinical and Economic Impact of Teleneurology vs Standard in Clinic Care for Multiple Sclerosis: A Randomized Trial
远程神经学与多发性硬化症临床护理标准的临床和经济影响:随机试验
- 批准号:
10583096 - 财政年份:2022
- 资助金额:
$ 15.76万 - 项目类别:
Liver Cirrhosis Network: Clinical Research Center - Mayo Clinic
肝硬化网络:临床研究中心 - 梅奥诊所
- 批准号:
10487453 - 财政年份:2021
- 资助金额:
$ 15.76万 - 项目类别:
Liver Cirrhosis Network: Clinical Research Center - Mayo Clinic
肝硬化网络:临床研究中心 - 梅奥诊所
- 批准号:
10310667 - 财政年份:2021
- 资助金额:
$ 15.76万 - 项目类别:
Liver Cirrhosis Network: Clinical Research Center - Mayo Clinic
肝硬化网络:临床研究中心 - 梅奥诊所
- 批准号:
10700154 - 财政年份:2021
- 资助金额:
$ 15.76万 - 项目类别: